CME Cme Group Earnings and EPS analysis

EPS in 2026 (TTM): $11.8

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the EPS for the trailing twelve months is $11.8. Cme Group's EPS for 2025 amounted to $11.18, marking an increase from $9.69 in 2024. During the quarterly period ending on Mar 31, 2026, CME's EPS stood at $3.25.

Cme Group had an annual EPS of $11.18, indicating an increase of 15.4% from $9.69 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $3.25, indicating a 23.6% increase from the same quarter last year. CME's 12-month EPS stands at $11.8 as of March 2026. Cme Group's annual EPS in 2024 stood at $9.69, a 9.2% increase year-over-year.

During the last 12 months, Cme Group has seen an EPS growth of 23.6% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 14.7% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 13.7%. A 10-year view shows that CME has seen an average EPS growth of 11.7% per year.